Australia Urinalysis Market (2024-2029)
The Australia Urinalysis Market was valued at $42.2 Million in 2024 and projected to reach to $64.9 Million by 2029, representing a compound annual growth rate of 9.0%. Australia's urinalysis market is positioned for sustained growth through 2029, supported by an aging population requiring increased diagnostic monitoring and a healthcare system investing in advanced laboratory technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia Urinalysis Market Trends and Insights
- This 9.0% compound annual growth rate reflects Australia's advancing healthcare infrastructure and increasing demand for diagnostic testing services.
- Australia's market is driven by rising prevalence of chronic diseases, aging population demographics, and enhanced adoption of automated urinalysis systems in clinical laboratories across the country. The Australian urinalysis sector benefits from strong regulatory frameworks and high healthcare spending per capita, positioning Australia as a mature market within the Asia Pacific region.
- Australia's healthcare providers are increasingly investing in point-of-care testing and laboratory automation, which are expected to accelerate market expansion through 2029.
- The competitive landscape in Australia features both established diagnostic manufacturers and emerging local players focused on improving test accuracy and turnaround times..
Key Market Statistics
- CAGR (2024-2029) 9.0% CAGR
- Market Size, 2024 ~USD 42.2 Million
- Forecast, 2029 ~USD 64.9 Million
- Country Australia
Australia Urinalysis Market Overview
Market Valuation :
Australia's urinalysis market is valued at $42.2 million in 2024, with projections reaching $64.9 million by 2029, representing a robust 9.0% CAGR driven by healthcare modernization.
Aging Population Impact :
Australia's demographic shift toward an older population is significantly increasing demand for diagnostic testing services, as chronic disease prevalence rises among seniors requiring regular urinalysis screening.
Healthcare Infrastructure Growth :
Advances in Australian healthcare infrastructure, including expanded pathology networks and laboratory automation, are enhancing accessibility and efficiency of urinalysis testing across urban and regional areas.
Chronic Disease Management :
Rising prevalence of diabetes, hypertension, and kidney disease in Australia is driving increased adoption of urinalysis as a critical diagnostic tool for disease monitoring and early detection.
Australia Urinalysis Market Dynamics
- The 9.0% CAGR reflects strong demand from both public and private healthcare sectors, with pathology providers expanding service offerings to meet growing patient needs. Key growth drivers include rising chronic disease prevalence, improved healthcare accessibility in regional areas, and increasing adoption of automated urinalysis systems in Australian laboratories.
- Government initiatives supporting preventive healthcare and early disease detection further strengthen market expansion, positioning Australia as a significant contributor to the Asia-Pacific urinalysis market..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Australia's urinalysis market is valued at $42.2 million in 2024 and will reach $64.9 million by 2029, representing a 9.0% CAGR.
- Australia's aging population and rising chronic disease prevalence are primary drivers of urinalysis demand across the country.
- Automated laboratory systems and point-of-care testing technologies are transforming Australia's diagnostic testing landscape.
- Australia's mature healthcare infrastructure and regulatory environment support sustained market growth through 2029.
Urinalysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOSPITALS & CLINICS (End User) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.6% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.3 (2024) |
| Revenue Forecast (Billions) | ~USD 6.8 (2029) |
| Segments Covered | Product, Type, Test Type, Application, End User |
Australia Urinalysis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Automated Urine Analyzers
- Biochemical Urine Analyzers
- Brazil
- Diabetes
- Dipsticks
- Disposables
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Kidney Diseases
- Laboratory Tests
- Liver Diseases
- Mexico
- Microscopy Analyzers
- Other Disease Screening Applications
- Poc Tests
- Point-Of-Care Urine Analyzers
- Pregnancy & Fertility Kits
- Reagents
- Rest Of Latam
- Sediment Urine Analyzers
- Semi-Automated Urine Analyzers
- Urinary Tract Infections
By Test Type
- Biochemical Tests
- Pregnancy & Fertility Tests
- Sediment Urinalysis
By Application
- Disease Screening
- Pregnancy & Fertility Testing
By End User
- Diagnostic Laboratories
- Home Care Settings
- Hospitals & Clinics
- Research Laboratories & Institutes
AUSTRALIA: URINALYSIS MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DIAGNOSTIC LABORATORIES | 18.63 | 19.2 | 20 | 20.99 | 22.19 | 23.73 | 25.63 | 27.98 | 7 |
| HOME CARE SETTINGS | 13.2 | 13.66 | 14.31 | 15.1 | 16.08 | 17.32 | 18.85 | 20.76 | 7.7 |
| HOSPITALS & CLINICS | 15.48 | 16.55 | 17.89 | 19.51 | 21.45 | 23.87 | 26.85 | 30.55 | 11.3 |
| RESEARCH LABORATORIES & INSTITUTES | 3.47 | 3.55 | 3.67 | 3.82 | 4.02 | 4.28 | 4.6 | 5 | 6.4 |
| TOTAL | 50.78 | 52.96 | 55.87 | 59.43 | 63.74 | 69.19 | 75.93 | 84.3 | 8.6 |
Target Audience
- Diagnostic Equipment Manufacturers : Need Australia-specific market data to assess demand for urinalysis analyzers, reagents, and laboratory automation systems within the growing $64.9M market opportunity.
- Pathology Service Providers : Require detailed market insights to evaluate expansion opportunities, service offerings, and competitive positioning within Australia's healthcare diagnostic sector.
- Healthcare Investment Firms : Seek comprehensive market analysis to identify investment opportunities in Australian pathology networks, diagnostic centers, and healthcare technology companies.
- Government & Health Policy Makers : Need market data to inform healthcare policy decisions, funding allocations, and strategic planning for diagnostic services across Australia's public health system.
- Medical Technology Distributors : Require Australia-specific market forecasts and growth drivers to optimize inventory planning, sales strategies, and partnership development in the urinalysis sector.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise valuation data for Australia's urinalysis market ($42.2M in 2024) with verified 9.0% CAGR forecasts through 2029, enabling accurate business planning and investment decisions.
- Competitive Landscape Intelligence : Understand Australia-specific market dynamics, key players, and competitive positioning within the urinalysis sector to identify partnership opportunities and market entry strategies.
- Demographic & Clinical Insights : Access detailed analysis of Australia's aging population trends and chronic disease prevalence driving urinalysis demand, supporting targeted marketing and product development strategies.
- Regional Expansion Strategy : Leverage Australia-specific healthcare infrastructure data and regional growth patterns to develop localized expansion plans for pathology services and diagnostic solutions.
- Regulatory & Reimbursement Framework : Gain insights into Australia's healthcare reimbursement policies, regulatory requirements, and pathology funding mechanisms essential for market entry and revenue forecasting.
Frequently asked questions
What is the current size of Australia's urinalysis market?
Australia's urinalysis market was valued at $42.2 million in 2024 and is expected to grow to $64.9 million by 2029.
What is the projected growth rate for Australia's urinalysis market?
Australia's urinalysis market is projected to grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2029.
What factors are driving growth in Australia's urinalysis market?
Key drivers include Australia's aging population, rising prevalence of chronic diseases, increased adoption of automated laboratory systems, and strong healthcare infrastructure investment.
Which segments are most important in Australia's urinalysis market?
Australia's market is segmented by testing type, end-user facilities (hospitals, clinics, laboratories), and technology platforms, with automated systems gaining significant market share.
How does Australia's urinalysis market compare to other Asia Pacific countries?
Australia represents a mature, high-value market within Asia Pacific, characterized by advanced healthcare infrastructure, strong regulatory standards, and higher per-capita diagnostic spending than regional peers.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Get the Full Urinalysis Market Report
Full forecast, segment splits, and company analysis for all Urinalysis Market.
- Mexico Urinalysis Market
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
- Canada Urinalysis Market
- US Urinalysis Market
- Germany Urinalysis Market
- UK Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- China Urinalysis Market
- Japan Urinalysis Market
- India Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
